335 related articles for article (PubMed ID: 24814894)
1. Blood biomarkers and their potential role in pulmonary arterial hypertension associated with congenital heart disease. a systematic review.
Giannakoulas G; Mouratoglou SA; Gatzoulis MA; Karvounis H
Int J Cardiol; 2014 Jul; 174(3):618-23. PubMed ID: 24814894
[TBL] [Abstract][Full Text] [Related]
2. Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
Li G; Li Y; Tan XQ; Jia P; Zhao J; Liu D; Wang T; Liu B
Pediatr Cardiol; 2017 Dec; 38(8):1620-1626. PubMed ID: 28819713
[TBL] [Abstract][Full Text] [Related]
3. Iron deficiency in pulmonary arterial hypertension associated with congenital heart disease.
Yu X; Zhang Y; Luo Q; Liu Z; Zhao Z; Zhao Q; Gao L; Jin Q; Yan L
Scand Cardiovasc J; 2018 Dec; 52(6):378-382. PubMed ID: 30632395
[TBL] [Abstract][Full Text] [Related]
4. The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.
Thakkar V; Stevens W; Prior D; Rabusa C; Sahhar J; Walker JG; Roddy J; Lester S; Rischmueller M; Zochling J; Nash P; Gabbay E; Youssef P; Proudman SM; Nikpour M
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):129-136. PubMed ID: 27214686
[TBL] [Abstract][Full Text] [Related]
5. Elevated Plasma Connective Tissue Growth Factor Levels in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
Li G; Tang L; Jia P; Zhao J; Liu D; Liu B
Pediatr Cardiol; 2016 Apr; 37(4):714-21. PubMed ID: 26714814
[TBL] [Abstract][Full Text] [Related]
6. Asymmetric Dimethyl-L-Arginine is a Biomarker for Disease Stage and Follow-Up of Pulmonary Hypertension Associated with Congenital Heart Disease.
Fang ZF; Huang YY; Tang L; Hu XQ; Shen XQ; Tang JJ; Zhou SH
Pediatr Cardiol; 2015 Jun; 36(5):1062-9. PubMed ID: 25737007
[TBL] [Abstract][Full Text] [Related]
7. Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.
Chung L; Fairchild RM; Furst DE; Li S; Alkassab F; Bolster MB; Csuka ME; Derk CT; Domsic RT; Fischer A; Frech TM; Gomberg-Maitland M; Gordon JK; Hinchcliff M; Hsu V; Hummers LK; Khanna D; Medsger TAJ; Molitor JA; Preston IR; Schiopu E; Shapiro L; Hant F; Silver R; Simms R; Varga J; Steen VD; Zamanian RT
Clin Exp Rheumatol; 2017; 35 Suppl 106(4):106-113. PubMed ID: 27908301
[TBL] [Abstract][Full Text] [Related]
8. Asymmetric Dimethylarginine and NT-proBNP Levels Provide Synergistic Information in Pulmonary Arterial Hypertension.
Shafran I; Probst V; Panzenböck A; Sadushi-Kolici R; Gerges C; Wolzt M; Segel MJ; Celermajer DS; Lang IM; Skoro-Sajer N
JACC Heart Fail; 2024 Jun; 12(6):1089-1097. PubMed ID: 38573264
[TBL] [Abstract][Full Text] [Related]
9. Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis.
Cavagna L; Caporali R; Klersy C; Ghio S; Albertini R; Scelsi L; Moratti R; Bonino C; Montecucco C
J Rheumatol; 2010 Oct; 37(10):2064-70. PubMed ID: 20634241
[TBL] [Abstract][Full Text] [Related]
10. [Clinical value of ADMA in patients with pulmonary arterial hypertension combination with congenital heart disease].
Chen P; Huang Y; Fang Z; Hu X; Shen X; Zhou S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 42(1):35-40. PubMed ID: 28216495
[TBL] [Abstract][Full Text] [Related]
11. Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease-Associated Pulmonary Hypertension.
Daly CM; Griffiths M; Simpson CE; Yang J; Damico RL; Vaidya RD; Williams M; Brandal S; Jone PN; Polsen C; Ivy DD; Austin ED; Nichols WC; Pauciulo MW; Lutz K; Nies MK; Rosenzweig EB; Hirsch R; Yung D; Everett AD
J Am Heart Assoc; 2021 Oct; 10(20):e021409. PubMed ID: 34622662
[TBL] [Abstract][Full Text] [Related]
12. Red blood cell distribution width in addition to N-terminal prohormone of B-type natriuretic peptide concentration improves assessment of risk of cardiovascular events in adult patients with congenital heart disease.
Martínez-Quintana E; Estupiñán-León H; Riaño-Ruiz M; Rodríguez-González F; Tugores A
Arch Cardiovasc Dis; 2020 Oct; 113(10):607-616. PubMed ID: 33039325
[TBL] [Abstract][Full Text] [Related]
13. The role of cystatin C as a biomarker for prognosis in pulmonary arterial hypertension due to congenital heart disease.
Blok IM; van Riel AC; Schuuring MJ; de Bruin-Bon RH; van Dijk AP; Hoendermis ES; Zwinderman AH; Mulder BJ; Bouma BJ
Int J Cardiol; 2016 Apr; 209():242-7. PubMed ID: 26897077
[TBL] [Abstract][Full Text] [Related]
14. Plasma Connective Tissue Growth Factor as a Biomarker of Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Adults.
Liu W; Hua Y; Zheng D; Lv W; Zhang W; Chen Q; Huang R; Li X
Circ J; 2023 Mar; 87(4):527-535. PubMed ID: 36843115
[TBL] [Abstract][Full Text] [Related]
15. Elevated homocysteine and asymmetric dimethyl arginine levels in pulmonary hypertension associated with congenital heart disease.
Sanli C; Oguz D; Olgunturk R; Tunaoglu FS; Kula S; Pasaoglu H; Gulbahar O; Cevik A
Pediatr Cardiol; 2012 Dec; 33(8):1323-31. PubMed ID: 22526220
[TBL] [Abstract][Full Text] [Related]
16. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.
Rotondo C; Praino E; Nivuori M; di Serio F; Lapadula G; Iannone F
Int J Rheum Dis; 2017 Jan; 20(1):90-96. PubMed ID: 26218502
[TBL] [Abstract][Full Text] [Related]
17. Effect of iloprost on biomarkers in patients with congenital heart disease-pulmonary arterial hypertension.
Li XY; Zheng Y; Long Y; Zhang X; Zhang L; Tian D; Zhou D; Lv QZ
Clin Exp Pharmacol Physiol; 2017 Sep; 44(9):914-923. PubMed ID: 28608969
[TBL] [Abstract][Full Text] [Related]
18. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.
Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J
Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension.
Al-Naamani N; Palevsky HI; Lederer DJ; Horn EM; Mathai SC; Roberts KE; Tracy RP; Hassoun PM; Girgis RE; Shimbo D; Post WS; Kawut SM;
Ann Am Thorac Soc; 2016 Jan; 13(1):25-30. PubMed ID: 26501464
[TBL] [Abstract][Full Text] [Related]
20. New predictors of mortality in adults with congenital heart disease and pulmonary hypertension: Midterm outcome of a prospective study.
Schuuring MJ; van Riel AC; Vis JC; Duffels MG; van Dijk AP; de Bruin-Bon RH; Zwinderman AH; Mulder BJ; Bouma BJ
Int J Cardiol; 2015 Feb; 181():270-6. PubMed ID: 25535690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
